8 studies found for:    "Signet ring cell carcinoma"
Show Display Options
Rank Status Study
1 Completed Prognosis of Signet Ring Cells in Upper Digestive Neoplasms
Conditions: Signet Ring Cell Carcinoma;   Stomach Disease;   Oesophagus;   Prognostic;   Case-control Study
Intervention:
2 Active, not recruiting Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
Conditions: Colon Mucinous Adenocarcinoma;   Colon Signet Ring Cell Adenocarcinoma;   Rectal Mucinous Adenocarcinoma;   Rectal Signet Ring Cell Adenocarcinoma;   Recurrent Colon Carcinoma;   Recurrent Rectal Carcinoma;   Stage IIIA Colon Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Colon Cancer;   Stage IIIC Rectal Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Rectal Cancer
Interventions: Drug: Akt Inhibitor MK2206;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
3 Terminated Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer
Conditions: Colon Mucinous Adenocarcinoma;   Colon Signet Ring Cell Adenocarcinoma;   Rectal Mucinous Adenocarcinoma;   Rectal Signet Ring Cell Adenocarcinoma;   Recurrent Colon Carcinoma;   Recurrent Rectal Carcinoma;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Rectal Cancer
Interventions: Biological: Cetuximab;   Drug: Gamma-Secretase Inhibitor RO4929097;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
4 Active, not recruiting Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial
Condition: Metastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal Junction
Interventions: Drug: S-1 (Tegafur/Gimeracil/Oteracil) /cisplatin (investigational arm);   Drug: Fluorouracil/cisplatin (control arm)
5 Not yet recruiting Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Device: Boston Scientific Large Capacity with needle Biopsy;   Device: Endodrill 1A (BIBBInstruments, Lund, Sweden)
6 Recruiting Hereditary Colorectal and Associated Tumor Registry Study
Conditions: Lynch Syndrome;   FAP;   Hereditary Diffuse Gastric Cancer;   Juvenile Polyposis Syndrome;   Peutz-Jeghers Syndrome
Intervention: Other: Research Registry
7 Active, not recruiting Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Conditions: Colon Mucinous Adenocarcinoma;   Colon Signet Ring Cell Adenocarcinoma;   Lynch Syndrome;   Stage IIA Colon Cancer;   Stage IIB Colon Cancer;   Stage IIC Colon Cancer
Interventions: Biological: Bevacizumab;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Oxaliplatin
8 Completed Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma
Conditions: Adenocarcinoma;   Esophageal Cancer
Intervention:

Indicates status has not been verified in more than two years